Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits
- PMID: 11683247
- DOI: 10.1023/a:1013046229699
Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits
Abstract
Purpose: We investigated the effect of meropenem (MEPM) on the disposition kinetics of valproate (VPA) and its metabolites in rabbits.
Methods: Rabbits were given 75 mg/kg VPA intravenously with or without 300 mg/kg MEPM.
Results: The plamsa total clearance of VPA was significantly increased to about 1.5 times the control (6.09 mL/min/kg vs. 4.28 mL/min/kg) by MEPM (P < 0.05). The values of the area under the plasma concentration-time curve (AUC) of 2-en-VPA, a product of beta-oxidation, and VPA-glucuronide (VPA-G) were significantly decreased to about 55% and 78% of the control, respectively (P < 0.05). The cumulative urinary excretions of VPA in the control and MEPM-treated groups were 0.54% and 0.62% of the dose, respectively, whereas those of VPA-G were 45.6% and 62.5%, respectively. The urinary excretion of VPA-G was significantly increased by MEPM (P < 0.05). Further, in the case of 33.8 mg/kg VPA-G administered intravenously the AUC value of VPA-G was unchanged by MEPM, whereas that of the generated VPA was significantly decreased to about half of the control.
Conclusions: The increase of the total clearance of VPA caused by MEPM appears to be a consequence of increased renal clearance of VPA-G, as well as suppression of VPA-G hydrolysis in the liver.
Similar articles
-
Drug-drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients.J Clin Pharm Ther. 2017 Apr;42(2):221-227. doi: 10.1111/jcpt.12501. Epub 2017 Feb 1. J Clin Pharm Ther. 2017. PMID: 28145574
-
PBPK modelling for the evaluation of drug-drug interaction between meropenem and valproic acid.Br J Clin Pharmacol. 2025 Apr;91(4):1198-1207. doi: 10.1111/bcp.16350. Epub 2024 Nov 22. Br J Clin Pharmacol. 2025. PMID: 39578702
-
Concentration-dependent disposition of glucuronide metabolite of valproate.J Pharm Pharmacol. 2002 May;54(5):633-9. doi: 10.1211/0022357021778943. J Pharm Pharmacol. 2002. PMID: 12005358
-
Interaction between valproic acid and carbapenem antibiotics.Drug Metab Rev. 2007;39(4):647-57. doi: 10.1080/03602530701690341. Drug Metab Rev. 2007. PMID: 18058328 Review.
-
Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.Eur J Clin Pharmacol. 2018 Apr;74(4):433-442. doi: 10.1007/s00228-017-2395-z. Epub 2017 Dec 14. Eur J Clin Pharmacol. 2018. PMID: 29243113 Review.
Cited by
-
Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient.Br J Clin Pharmacol. 2005 May;59(5):593-7. doi: 10.1111/j.1365-2125.2005.02339.x. Br J Clin Pharmacol. 2005. PMID: 15842559 Free PMC article.
-
Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics.Eur J Drug Metab Pharmacokinet. 2017 Dec;42(6):965-972. doi: 10.1007/s13318-017-0413-2. Eur J Drug Metab Pharmacokinet. 2017. PMID: 28447323
-
Molecular and therapeutic potential and toxicity of valproic acid.J Biomed Biotechnol. 2010;2010:479364. doi: 10.1155/2010/479364. Epub 2010 Jul 29. J Biomed Biotechnol. 2010. PMID: 20798865 Free PMC article. Review.
-
Unusual drug reaction between valproate sodium and meropenem.Int J Clin Pharm. 2013 Jun;35(3):316-8. doi: 10.1007/s11096-013-9763-2. Epub 2013 Mar 13. Int J Clin Pharm. 2013. PMID: 23483443
-
Cryo-EM structure of acylpeptide hydrolase reveals substrate selection by multimerization and a multi-state serine-protease triad.Chem Sci. 2022 May 18;13(24):7132-7142. doi: 10.1039/d2sc02276a. eCollection 2022 Jun 22. Chem Sci. 2022. PMID: 35799812 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials